Cases
Representative Work: Acted for Servier Canada, in the context of their $21,000,000 investment along with Fonds de solidarite FTQ
CTI Life Sciences Fund to create ILKOS THERAPEUTICS inc., a new Quebec biotechnology firm.
Acted for CiToxLAB Group Inc. in connection with its acquisition of AccelLAB Inc.
Acted for ProMetic Life Sciences Inc., a Toronto Stock Exchange listed issuer, in connection with the closing of a bought deal public offering of 19,400,000 common shares, conducted through a syndicate of underwriters, for aggregate gross proceeds of $60,140,000
the concurrent private placement entered into with Structured Alpha LP, for the subscription of 1,921,776 common shares.
Acted for O'Leary Funds Management LP in connection with the sale of its mutual fund business to Canoe Financial LP.
Represented MRRM Inc. in the context of its going-private transaction
amalgamation with a wholly-owned subsidiary of Marbour S.A.S.
Acted for Qwave Capital LLC, a U.S. based private equity firm, in connection with its $17 million unsolicited take-over bid on the TSX Venture Exchange listed online lending company, IOU Financial Inc.
Acted for the underwriters in the context of a bought deal offering under a short form prospectus of convertible unsecured subordinated debentures of Innergex Renewable Energy Inc. for an aggregate principal amount of $100 million.
Advised Doris Inc.
its shareholders in connection with the sale of Doris' Canadian, US
Hong Kong business to Gildan Activewear Inc.
Acted for ProMetic Life Sciences Inc. in connection with a bought deal public offering of 13,200,000 common shares, conducted through a syndicate of underwriters, for aggregate gross proceeds of $25,080,000.
Represented BDC Venture Capital
Investissement Quebec in the context of their investment in White Star Capital, a transatlantic seed vehicle based in Guernsey investing in start-up companies in the fields of social media, gaming
e-commerce.
Acted as Canadian counsel to Strides Arcolab Limited in the context of the sale of their Agila Specialties Pharma Corporation business to Mylan Inc. for a total consideration of up to US$1.75 billion.
Acted for ProMetic Life Sciences Inc. in connection with its public offering of a total to 26,651,400 common shares conducted on a best efforts basis by a syndicate of agents, for total gross proceeds of $23,986,260.
Acted for Northl
Power in bidding on a call for tenders by Hydro-Quebec for a 450 megawatt wind farm project.
Acted as Canadian counsel for the banks that led the syndicate financing the offering of senior notes for Quebecor Media Inc. consisting of a Canadian tranche of $500 million
an American tranche of $850 million.
Acted for Eaton Vance Corp. in respect of its acquisition of an interest in Hexavest Inc., a Quebec-based fund manager.
Advised institutional investors in respect of the creation of iNovia Fund III, a $110-million venture capital fund with a focus on the digital media, Internet
communications sectors.
Acted for Aurvista Gold Corporation (TSX-V: AVA) in connection with its acquisition of a 100% interest in certain gold mining claims in Northern Quebec
its concurrent initial public offering of shares
initial listing on the TSX-V. Pursuant to the IPO, Aurvista issued units comprising one common share
one-half of one common share purchase warrant, as well as common shares that qualify as flow-through shares as defined in the Income Tax Act (Canada).
Acted for Sky Alliance Resources Guinee SA in connection with its reverse take-over of the TSX-V-listed mining company now known as West African Iron Ore Corp. (formerly Westward Explorations Ltd.) (TSX-V: WAI) with mining assets in Guinea. This transaction was completed, concurrently with a private placement financing.
Acted for A&D Prevost Inc., a North American leader in the field of architectural aluminum, in connection with a change of control transaction involving a $30-million investment by Capital regional et cooperatif Desjardins.
